Banerji Aleena, Clark Sunday, Afilalo Marc, Blanda Michelle P, Cydulka Rita K, Camargo Carlos A
Department of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
J Am Geriatr Soc. 2006 Jan;54(1):48-55. doi: 10.1111/j.1532-5415.2005.00563.x.
To describe acute asthma in younger versus older adults presenting to the emergency department (ED).
Prospective cohort study. Asthmatic adults were divided into three age groups: 18 to 34, 35 to 54, and 55 and older. The analysis was restricted to never smokers and smokers with fewer than 10 pack-years.
ED.
Two thousand sixty-four patients aged 18 and older with a physician diagnosis of asthma.
Medications and peak expiratory flow.
There were 1,158 (56%) subjects aged 18 to 34; 777 (37%) aged 35 to 54; and 129 (6%) aged 55 and older. Older patients were most likely to have a primary care provider (65%, 74%, and 91%, respectively; P<.001); most were not taking inhaled corticosteroids (39%, 55%, and 48%, respectively; P<.001). Older patients reported fewer ED visits for asthma (2, 2, and 1, respectively; P=.001) but were more likely to report asthma hospitalization (24%, 31%, and 37%, respectively; P<.001). All groups had severe exacerbations (initial percentage predicted peak flow: 47, 47, and 47, respectively; P=.50), but older patients were least likely to report severe symptoms (72%, 79%, and 67%, respectively; P=.001). Older patients did not respond as well to bronchodilators, even after controlling for other demographic factors, markers of asthma severity, and ED management (change between initial and final peak expiratory flow, using subjects aged 18 to 34 as reference: aged 35-54, beta=-0.7 (95% CI=-9.4-8.0); aged > or = 55, beta=-18.4 (-31.9 to -4.9)). The smaller change in peak expiratory flow contributed most to older patients' greater likelihood of hospitalization.
Older asthma patients were less responsive to emergency bronchodilation. This may reflect chronic undertreatment with inhaled corticosteroids.
描述急诊科(ED)中年轻与年长成年急性哮喘患者的情况。
前瞻性队列研究。成年哮喘患者被分为三个年龄组:18至34岁、35至54岁以及55岁及以上。分析仅限于从不吸烟者以及吸烟史少于10包年的吸烟者。
急诊科。
264名年龄在18岁及以上且经医生诊断为哮喘的患者。
药物治疗及呼气峰值流速。
18至34岁的受试者有1158名(56%);35至54岁的有777名(37%);55岁及以上的有129名(6%)。年长患者最有可能有初级保健医生(分别为65%、74%和91%;P<0.001);大多数未使用吸入性糖皮质激素(分别为39%、55%和48%;P<0.001)。年长患者因哮喘就诊急诊科的次数较少(分别为2次、2次和1次;P=0.001),但更有可能报告因哮喘住院(分别为24%、31%和37%;P<0.001)。所有组均有严重加重情况(初始预计呼气峰值流速百分比:分别为47、47和47;P=0.50),但年长患者报告严重症状的可能性最小(分别为72%、79%和67%;P=0.001)。即使在控制了其他人口统计学因素、哮喘严重程度标志物及急诊科处理措施后,年长患者对支气管扩张剂的反应仍较差(以18至34岁的患者为参照,初始与最终呼气峰值流速的变化:35至54岁,β=-0.7(95%CI=-9.4至8.0);55岁及以上,β=-18.4(-31.9至-4.9))。呼气峰值流速变化较小是年长患者住院可能性较大的最主要原因。
年长哮喘患者对紧急支气管扩张治疗反应较差。这可能反映出吸入性糖皮质激素长期治疗不足。